Stockscreener 앱 받기
4.20
3.23%
-0.14
시간 외 거래:
4.45
0.25
+5.95%
전일 마감가:
$4.34
열려 있는:
$4.26
하루 거래량:
373.07K
Relative Volume:
0.13
시가총액:
$53.09M
수익:
-
순이익/손실:
$-30.54M
주가수익비율:
-2.7097
EPS:
-1.55
순현금흐름:
$-18.30M
1주 성능:
-13.76%
1개월 성능:
-14.29%
6개월 성능:
+584.26%
1년 성능:
+884.30%
1일 변동 폭
$4.10
$4.32
1주일 범위
$4.10
$4.94
52주 변동 폭
$0.202
$8.2457
Unicycive Therapeutics Inc Stock (UNCY) Company Profile
명칭
Unicycive Therapeutics Inc
전화
650-384-0642
주소
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS
UNCY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UNCY
Unicycive Therapeutics Inc
|
4.20 | 55.41M | 0 | -30.54M | -18.30M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-21 | 개시 | Guggenheim | Buy |
| 2024-04-04 | 개시 | Piper Sandler | Overweight |
Unicycive Therapeutics Inc 주식(UNCY)의 최신 뉴스
Unicycive Therapeutics Inc. stock trendline breakdownWeekly Stock Picks with Trend Confidence - Newser
Is it time to cut losses on Unicycive Therapeutics Inc.Pattern Breakout Prediction for Short Term - Newser
Real time pattern detection on Unicycive Therapeutics Inc. stockPrice Action Based Buy Zone Forecast - Newser
Momentum divergence signals in Unicycive Therapeutics Inc. chartExit Strategy Guide With Risk Control Plan - Newser
Quantitative breakdown of Unicycive Therapeutics Inc. recent moveDaily Investment Ideas with Market Insight - Newser
Unicycive Therapeutics Inc. stock trend forecastDaily Upside Movement Prediction With Data - Newser
How many analysts rate Unicycive Therapeutics Inc. as a “Buy”Best Dividend Tips From AI Tools - jammulinksnews.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc.UNCY - PR Newswire
Does Unicycive Therapeutics Inc. fit your quant trading modelLong Term Equity Screener with Safety Metrics - Newser
How does Unicycive Therapeutics Inc. compare to its industry peersPre Market Ideas For Beginners - jammulinksnews.com
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
Real time social sentiment graph for Unicycive Therapeutics Inc.Smart Money Tracking Signal Generator Activated - metal.it
Unicycive Therapeutics, Inc.'s (NASDAQ:UNCY) Path To Profitability - 富途牛牛
Unicycive Therapeutics (NASDAQ:UNCY) Trading Down 6.2% – Here’s What Happened - Defense World
Why Unicycive Therapeutics Inc. stock attracts strong analyst attentionFree Alpha Driven Watchlist With Alerts - Newser
Evaluating Unicycive Therapeutics Inc. with trendline analysisReal Time Alert System for Market Moves - Newser
What high frequency data says about Unicycive Therapeutics Inc.Price Action Based Buy Zone Forecast - Newser
Published on: 2025-07-29 22:28:57 - metal.it
Elliott Wave Theory Predicts Pullback in Unicycive Therapeutics Inc.Low Drawdown Real Time Trading Tips Shared - metal.it
Published on: 2025-07-29 06:06:35 - Newser
How Unicycive Therapeutics Inc. stock performs during market volatilityHigh Return Trade Roadmap with Setup Filters - Newser
Short Term Charts Align With Long Term Uptrend in Unicycive Therapeutics Inc.Fundamental + Technical Hybrid Stock Tips Shared - beatles.ru
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Unicycive Therapeutics, Inc. (UNCY) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Perspective Therapeutics shares fall 1.48% premarket after Unicycive Therapeutics receives FDA CRL. - AInvest
What are the latest earnings results for Unicycive Therapeutics Inc.Accelerated profit realization - jammulinksnews.com
When is Unicycive Therapeutics Inc. stock expected to show significant growthTriple-digit wealth increases - jammulinksnews.com
What are analysts’ price targets for Unicycive Therapeutics Inc. in the next 12 monthsTrack top-performing stocks effortlessly - jammulinksnews.com
What makes Unicycive Therapeutics Inc. stock price move sharplyUnlock daily market insights for better trades - jammulinksnews.com
What is the dividend policy of Unicycive Therapeutics Inc. stockUnlock daily market insights for better trades - jammulinksnews.com
Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
How Interest Rate Changes Impact Unicycive Therapeutics Inc. Stock PerformanceFree Top-Rated Stock Analysis - Newser
What analysts say about Unicycive Therapeutics Inc. stockSuperior trading gains - PrintWeekIndia
Unicycive Therapeutics Announces the Publication of - GlobeNewswire
Unicycive Therapeutics (UNCY) Publishes Promising Trial Data on CKD Treatment | UNCY Stock News - GuruFocus
Unicycive Therapeutics: Manageable CMC Speed-Bump—Pill-Burden Edge Intact, Buying Opportunity Pre-FDA Decision - AInvest
Unicycive Therapeutics: Manageable CMC Speed BumpPill Burden Edge Intact, Buying (UNCY) - Seeking Alpha
Unicycive Therapeutics Announces the Publication of Oxylanthanum Carbonate Pivotal Trial Data in Clinical Journal of the American Society of Nephrology - The Manila Times
Revolutionary Kidney Disease Drug Shows 90% Success Rate with Just 3 Pills Daily, New Study Reveals - Stock Titan
Unicycive Therapeutics Inc (UNCY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
0.15%
자본화:
|
볼륨(24시간):